Sutura Therapeutics is a biopharmaceutical company at the forefront of developing next-generation biomolecular medicines. Through its innovative drug conjugate platform, Sutura is advancing the field of biomolecular medicine to address the unmet medical needs of patients with diseases which were previously considered undruggable.

Biomolecule-based medicines have unique biological properties and actions, which make them promising in treating diseases. However, the size and shape of biomolecules often limit their capacity to enter cells and reach their target, making them less effective. Sutura’s drug conjugates platform is designed to overcome these limitations and has the potential to address a broad range of indications.

Biotechnology

Life Sciences

Pharmaceutical

Sutura Therapeutics Ltd

Edwin Wagena

Steve Cox

At Sutura Therapeutics Ltd, the Leadership Team, consisting of the Chief Executive Officer, Chief Business Officer, and Vice President of CMC, is responsible for steering the company's strategic direction, overseeing business operations, and ensuring the effective integration of research, development, and manufacturing processes. They provide critical oversight to advance the company’s drug conjugate platform and drive its mission to develop groundbreaking biomolecular medicines for unmet medical needs.

Leadership Team

About

Team members

Other teams at Sutura Therapeutics Ltd

Research and Development